yttrium Y 90 humanized epratuzumab

yttrium Y 90 humanized epratuzumab information and resources from the National Cancer Institute

NCI Thesaurus | yttrium Y 90 humanized epratuzumab

A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD222, delivering a cytotoxic dose of beta radiation. NCI Thesaurus | yttrium Y 90 humanized epratuzumab

A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD222, delivering a cytotoxic dose of beta radiation.

yttrium Y 90 humanized epratuzumab -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org